Clinical Trial

Dexamethasone Versus Dexmedetomidine in IPACK Block to Reduce Pain Post Arthroscopic Knee Surgeries

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated June 17, 2025 (before its estimated September 3, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators will test the effects of dexamethasone versus dexmedetomidine as adjuvant to bupivacaine in IPACK Block and it's direct effect in decreasing pain post operative following Arthroscopic knee surgeries
Trial Details
NCT Number NCT07024043
Lead Sponsor Ain Shams University
Conditions Efficacy of Drugs in Pain Management
Enrollment 75 participants
Start Date 2025-03-03
Primary Completion 2025-09-03 (estimated)
Study Completion 2025-09-03 (estimated)
Updated on ClinicalTrials.gov 2025-06-17